Business Standard

Astec Lifesciences standalone net profit declines 39.96% in the September 2017 quarter

Image

Capital Market

Sales rise 12.70% to Rs 95.93 crore

Net profit of Astec Lifesciences declined 39.96% to Rs 6.70 crore in the quarter ended September 2017 as against Rs 11.16 crore during the previous quarter ended September 2016. Sales rose 12.70% to Rs 95.93 crore in the quarter ended September 2017 as against Rs 85.12 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales95.9385.12 13 OPM %15.3127.29 -PBDT13.5920.35 -33 PBT10.0616.52 -39 NP6.7011.16 -40

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 26 2017 | 4:46 PM IST

Explore News